COLWELL: Indianapolis strategizes for health care reform
The recent flurry of big announcements portends well.
Health Care
Articles
MCDONALD: Groups making headway attacking health problems
The statistics we hear so often are clear. As a community, we are not in an enviable place. We smoke more, exercise less and weigh more than the national average, resulting in more diabetes than average.
Medical finance driving major changes in health care marketplace
Brian and Emily Kahn had virtually identical physical therapy. He paid much more than she did. Why? Because of where the therapy took place.
Lilly warehouse thieves had security report, lawsuit says
A federal lawsuit contends that thieves who broke into an Eli Lilly and Co. warehouse in Connecticut three years ago and stole more than $60 million worth of drugs obtained a copy of a report that revealed weaknesses in the building's security system.
New $100M plan to map human brain could boost Lilly
President Obama on Tuesday announced a campaign designed to develop treatments for some of the least understood brain disorders, an effort that could benefit health care giants Eli Lilly and Co. and others.
Indiana’s health care transparency laws get failing grade
Indiana’s laws requiring hospitals to release price information are woefully inadequate, according to a report by two health insurance reform groups. Indiana was among 29 states to receive an "F" grade.
J&J wins OK for first in new class of diabetes drugs
Johnson & Johnson, the world’s largest seller of health-care products, won approval for the first in a new family of diabetes drugs, giving them the edge against rivals including Eli Lilly and Co. that are developing similar medicines.
Study: Indiana individual health-claim costs to rise
A study by the nation's leading group of financial risk analysts shows the biggest driver of health insurance premiums will rise by more than 67 percent for Indiana residents' individual policies under President Barack Obama's health care overhaul.
Lilly, Boehringer submit diabetes drug to FDA
Eli Lilly and Co. said Monday that it has submitted a new type 2 diabetes treatment it is developing with German drugmaker Boehringer Ingelheim to the Food and Drug Administration.
Indiana lawmakers advance tighter cold meds limits
Consumers would face tighter limits on the quantities they could buy of cold and allergy pills often used to make methamphetamine under a proposal approved by Indiana lawmakers.
HealthLease to snare $141.7M in senior properties
A central Indiana REIT that went public in 2012 has agreed to buy 13 senior housing and care facilities in three states, growing its asset value by 50 percent.
Court may decide if drugmakers can pay to delay generics
Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines.
Company taps sports market with bacteria-stalking chemical
Anderson-based Coeus Technology has invented a chemical that kills dangerous bacteria, including potentially deadly staph, by forming a germ-killing barrier that lasts two weeks to six months.
Healthy Indiana Plan gets mixed reviews at hearing
Hospital officials praised Indiana's medical savings accounts but some consumer advocates panned them Wednesday during a public hearing as Gov. Mike Pence seeks federal approval to use the Healthy Indiana Plan to expand Medicaid in this state.
FDA probe of diabetes medications hurts drugmakers’ stock
Shares of several pharmaceutical companies that make diabetes medicines, including Eli Lilly, fell after U.S. regulators warned they are looking into potential risks of drugs in two classes of diabetes treatments.
Panel advances tougher synthetic drugs bill
Indiana lawmakers are advancing a bill that would make it illegal to possess or deal "lookalike" synthetic drugs similar to those known as "bath salts" and other nicknames.
Drugmakers, Interpol ramp up fight against fakes
More than two dozen of the world's largest pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs.
Analysis: Feds likely to cut Medicaid support
A fellow conservative provided some support for Gov. Mike Pence’s claim that an expansion of Medicaid will become a “baby elephant” that eats up larger and larger shares of state resources.
IU Health puts Methodist expansion plans on hold
Citing concerns about the economy and federal health reform, Indiana University Health has pressed pause on its plans to build a bed tower at Methodist Hospital that could have cost it as much as $500 million.
Overseas tax savings for U.S. drugmakers under threat
Eli Lilly and Co. and five other big drugmakers avoided paying $7 billion in U.S. taxes last year by shifting their profits overseas. The strategy has drawn the ire of some legislators.